Pfizer (PFE)

SG&A Expense Growth

15.20%

Quarterly · Period ending:

PFE logo

PFE SG&A Expense Growth

Latest reported15.20%
PFE Quarterly SG&A Growth (QoQ) (0.00% → 15.20%)
High-resolution chart · PNG

PFE sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
8.9147%
-16.0976%
13.9733%
-6.1565%
72.8803%
-4.6991%
18.5462%
-5.9425%
-0.3185%
-6.492%
26.9085%
-11.8%
12.6126%
-5.5989%
18.9713%
-4.739%
26.7821%
-43.5308%
20.2628%
-7.6628%
15.1471%
-9.5203%
14.618%
-2.302%
9.9795%
-2.438%
14.5604%
2.8249%
7.7954%
-47.0237%
88.2478%
30.347%
-20.73%
-10.4356%
18.204%
-2.4098%
6.7975%
-11.2465%
14.1204%
-1.2467%
8.5861%
-13.3297%
23.9731%
-1.5644%
11.6654%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.